Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:MRX

Medicis Pharmaceutical (MRX) Stock Price, News & Analysis

Medicis Pharmaceutical logo

About Medicis Pharmaceutical Stock (NYSE:MRX)

Advanced Chart

Key Stats

Today's Range
$32.54
$33.33
50-Day Range
N/A
52-Week Range
$18.13
$49.34
Volume
415,945 shs
Average Volume
644,091 shs
Market Capitalization
$2.47 billion
P/E Ratio
N/A
Dividend Yield
1.60%
Price Target
$45.14
Consensus Rating
Moderate Buy

Company Overview

Medicis Pharmaceutical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
26th Percentile Overall Score

MRX MarketRank™: 

Medicis Pharmaceutical scored higher than 26% of companies evaluated by MarketBeat, and ranked 845th out of 943 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Medicis Pharmaceutical has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 6 buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Medicis Pharmaceutical has only been the subject of 2 research reports in the past 90 days.

  • Read more about Medicis Pharmaceutical's stock forecast and price target.
  • Earnings Growth

    Earnings for Medicis Pharmaceutical are expected to decrease by -0.34% in the coming year, from $2.94 to $2.93 per share.

  • Short Interest

    There is no current short interest data available for MRX.
  • Dividend Yield

    Medicis Pharmaceutical pays a meaningful dividend of 1.44%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Medicis Pharmaceutical does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on earnings estimates, Medicis Pharmaceutical will have a dividend payout ratio of 19.11% next year. This indicates that Medicis Pharmaceutical will be able to sustain or increase its dividend.

  • Read more about Medicis Pharmaceutical's dividend.
  • Short Interest

    There is no current short interest data available for MRX.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Medicis Pharmaceutical this week, compared to 0 articles on an average week.
  • Search Interest

    9 people have searched for MRX on MarketBeat in the last 30 days. This is an increase of 125% compared to the previous 30 days.
Receive MRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicis Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

MRX Stock News Headlines

Marex Group plc (MRX) Q2 2025 Earnings Call Transcript
One stock to replace Nvidia
Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.
Marex Group plc announces second quarter 2025 results
See More Headlines

MRX Stock Analysis - Frequently Asked Questions

Medicis Pharmaceutical Corp (NYSE:MRX) issued its quarterly earnings data on Wednesday, August, 13th. The healthcare company reported $1.02 EPS for the quarter, beating the consensus estimate of $0.93 by $0.09. Medicis Pharmaceutical's quarterly revenue was up 18.5% on a year-over-year basis.

Medicis Pharmaceutical (MRX) raised $292 million in an initial public offering on Thursday, April 25th 2024. The company issued 15,384,615 shares at a price of $19.00 per share.

Medicis Pharmaceutical's top institutional shareholders include State of Tennessee Department of Treasury (0.17%), SG Americas Securities LLC (0.03%) and Simplex Trading LLC.

Based on aggregate information from My MarketBeat watchlists, some other companies that Medicis Pharmaceutical investors own include Tesla (TSLA), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX) and Home Depot (HD).

Company Calendar

Record date for 6/10 Dividend
5/27/2025
Ex-Dividend for 6/10 Dividend
5/27/2025
Dividend Payable
6/10/2025
Last Earnings
8/13/2025
Today
8/17/2025
Record date for 9/11 Dividend
8/26/2025
Ex-Dividend for 9/11 Dividend
8/26/2025
Dividend Payable
9/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Finance
Industry
Security & commodity brokers, dealers, exchanges & services
Sub-Industry
N/A
Current Symbol
NYSE:MRX
CIK
859368
Fax
N/A
Employees
2,074
Year Founded
N/A

Price Target and Rating

High Price Target
$54.00
Low Price Target
$34.00
Potential Upside/Downside
+28.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
1.18
Current Ratio
1.04
Quick Ratio
1.08

Sales & Book Value

Annual Sales
$1.24 billion
Price / Sales
1.98
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
70,290,000
Free Float
67,627,000
Market Cap
$2.47 billion
Optionable
Optionable
Beta
N/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NYSE:MRX) was last updated on 8/17/2025 by MarketBeat.com Staff
From Our Partners